Signal TransductionThrough Cytokine Receptors

References

• Hirano T., Nakajima K., Hibi M. Cytokine & Growth Factor Reviews. Signaling mechanisms through gp130: a model of the cytokine system. 1997, in press
   Google Scholar
• Bazan J. F. Haematopoietic receptors and helical cytokines. Immunol. Today 1990; 11: 350–354
   PubMedGoogle Scholar
• Miyajima A., Kitamura T., Harada N., Yokota T., Arai K. Cytokine receptors and signal transduction. Annu. Rev. Immunol. 1992; 10: 295–331
   PubMed Web of Science ®Google Scholar
• Ihle J. N., Kerr I. M. Jaks and Stats in signaling by the cytokine receptor superfamily. Trends. Genet. 1995; 11: 99–74
   Google Scholar
• Ihle J. N. Cytokine receptor signalling. Nature 1995; 377: 591–594
   PubMed Web of Science ®Google Scholar
• Darnell J. E.J., Kerr I. M., Stark G. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415–1421
   PubMed Web of Science ®Google Scholar
• Schindler C., Darnell J. E.J. Transcriptional responses to polypeptide ligands: the Jak-STAT pathway. Annu. Rev. Biochem. 1995; 64: 621–651
   PubMed Web of Science ®Google Scholar
• Ihle J. N. STATs: signal transducers and activators of transcription. Cell 1996; 84: 331–334
   PubMed Web of Science ®Google Scholar
• Hiton D. J., Watowich S. S., Kats L., Lodish H. F. Saturation mutagenesis of the WSXWS motif of the erythropoietin receptor. J. Biol. Chem. 1996; 271: 4699–4708
   Google Scholar
• Murakami M., Narazaki M., Hibi M., Yawata H., Yasukawa K., Hamaguchi M., Taga T., Kishimoto T. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc. Natl. Acad. Sci. USA 1991; 88: 11349–11353
   PubMed Web of Science ®Google Scholar
• Fukunaga R., Ishizaka-Ikeda E., Pan C. X., Seto Y., Nagata S. Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J. 1991; 10: 2855–2865
   PubMed Web of Science ®Google Scholar
• Narazaki M., Witthuhn B. A., Yoshida K., Silvennoinen O., Yasukawa K., Ihle J. N., Kishimoto T., Kishimoto T. Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130. Proc. Natl. Acad. Sci. USA 1994; 91: 2285–2289
   PubMed Web of Science ®Google Scholar
• Lebrun J. J., Ali S., Ullrich A., Kelly P. A. Proline-rich sequence-mediated JAK2 association to the prolactin receptor is required but not sufficient for signal transduction. J. Biol. Chem. 1995; 270: 10664–10670
   PubMedGoogle Scholar
• Wang Y. D., Wood W. I. Amino acids of the human growth hormone receptor that are required for proliferation and Jak-STAT signaling. Mol. Endocrinol. 1995; 9: 303–311
   Google Scholar
• Avalos B. R., Hunter M. G., Parker J. M., Ceselaki S. K., Drunker B. J., Corey S. J., Mehta V. B. Point mutations in the conserved boxl region inactivate the human granulocyte-colony stimulating factor receptor for growth signal transduction and tyrosine phosphorylation of p75 c-rel. Blood 1995; 85: 3117–3126
   PubMed Web of Science ®Google Scholar
• Tanner J. W., Chen W., Woung R. L., Lonmore G. D., Shaw A. S. The conserved boxl motif of cytokine receptor is required for association with JAK kinases. J. Biol. Chem. 1995; 270: 6523–6530
   PubMed Web of Science ®Google Scholar
• Mehler M. F., Kessler J. A. Hematolymphopoietic and inflammatory cytokines in neural development. Trends Neurosci. 1997; 20: 357–365
   PubMed Web of Science ®Google Scholar
• Hirano T., Matsuda T., Nakajima K. Signal transduction through gp130 that is shared among receptors for the interleukin 6 related cytokine subfamily. Stem Cell Dayt. 1994; 12: 262–277
   PubMed Web of Science ®Google Scholar
• Taga T., Kishimoto T. Signaling mechanisms through cytokine receptors that share signal transducing receptor components. Curr. Opin. Immunol. 1995; 7: 17–23
   PubMed Web of Science ®Google Scholar
• Hibi M., Nakajima K., Hirano T. IL-6 cytokine family and signal transduction: a model of cytokine system. J. Mol. Med. 1990; 74: 1–12
   Google Scholar
• Boulay J. L., Paul W. E. The interleukin-4 family lymphokines. Curr. Opin. Immunol. 1992; 4: 294–298
   Google Scholar
• Sugamura K., Asao H., Kondo M., Tanaka N., Ishii N., Nakamura M., Takeshita T. The common gamma-chain for multiple cytokine receptors. Adv. Immunol. 1995; 59: 225–277
   PubMed Web of Science ®Google Scholar
• Murakami M., Hibi M., Nakagawa N., Nakagawa T., Yasukawa K., Yamanishi K., Taga T., Kishimoto T. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 1993; 260: 1808–1810
   PubMed Web of Science ®Google Scholar
• Davis S., Aldrich T. H., Stahl N., Pan L., Taga T., Kishimoto T., Ip N. Y., Yancopoulos G. D. LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science 1993; 260: 1805–1808
   PubMed Web of Science ®Google Scholar
• Neddermann P., Graziani R., Ciliberto G., Paonessa G. Functional expression of soluble human interleukin-11 (IL-11) receptor alpha and stoichiometry of in vitro, IL-11 receptor complexes with gp130. J. Biol. Chem. 1996; 271: 30986–30991
   Google Scholar
• Kawahara A., Minami Y., Miyazaki T., Ihle J. N., Taniguchi T. Critical role of the interleukin 2 (IL-2) receptor gamma-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction. Proc. Natl. Acad. Sci. USA 1995; 92: 8724–8728
   PubMed Web of Science ®Google Scholar
• Kumanogo A., Marukawa S., Kumanogo T., Hirota H., Yoshida K., Lee I. S., Yasui T., Yoshida K., Taga T., Kishimoto T. Impairment of antigen-specific antibody production in transgenic mice expressing a dominant-negative form of gp130. Proc. Natl. Acad. Sci. USA 1997; 94: 2478–2482
   Google Scholar
• Watowich S. S., Yoshimura A., Longmore G. D., Hilton D. J., Yoshimura Y., Lodish H. F. Homodimerization and constitutive activation of the erythropoietin receptor. Proc. Natl. Acad. Sci. USA 1992; 89: 2140–2144
   PubMed Web of Science ®Google Scholar
• Heldin C. H. Dimerization of cell surface receptors in signal transduction. Cell 1995; 80: 213–223
   PubMed Web of Science ®Google Scholar
• Noguchi M., Yi H., Rosenblatt H. M., Filipovich A. H., Adelstein S., Modi W. S., McBride O. W., Leonard W. J. InterIeukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in human. Cell 1993; 73: 147–157
   PubMed Web of Science ®Google Scholar
• Macchi P., Villa A., Gillani S., Sacco M. G., Frattini A., Porta F., Ugazio A. G., Johnston J. A., Candotti F., O'Shea J. J., et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 1995; 377: 65–68
   PubMed Web of Science ®Google Scholar
• Russell S. M., Taybei N., Nakajima H., Riedy M. C., Roberts J. L., Aman M. J., Migone T. S., Noguchi M., Markert M. L., Buckley R. H., et al. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 1995; 270: 797–800
   PubMed Web of Science ®Google Scholar
• Marrero M. B., Schieffer B., Paxton W. G., Heerdt L., Berk B. C., Delafontaine P., Bernstein K. E. Direct stimulation of Jak/STAT pathway by the angiotensin II ATI receptor. Nature 1995; 375: 247–250
   PubMed Web of Science ®Google Scholar
• Danial N. N., Pernis A., Rothman P. B. Jak-STAT signaling induced by the v-abl oncogene. Science 1995; 269: 1875–1877
   PubMed Web of Science ®Google Scholar
• Wilks A. F., Harpur A. G., Kurban R. R., Ralph S. J., Zurcher G., Ziemiecki A. Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase. Mol. Cell. Biol. 1991; 11: 2057–2065
   PubMed Web of Science ®Google Scholar
• Velazquez L., Mogensen K. E., Barbieri G., Fellous M., Uzé G., Pellegrini S. Distinct domains of the protein-tyrosine kinase Tyk2 required for binding of interferon-alpha/beta and for signal transduction. J. Biol. Chem. 1995; 270: 3327–3334
   PubMedGoogle Scholar
• Fujitani Y., Hibi M., Fukada T., Takahashi-Tezuka M., Yoshida H., Yamaguchi T., Sugiyama K., Yamanaka Y., Nakajima K., Hirano T. An alternative pathway for STAT activation that is mediated by the direct interaction between Jak and STAT. Oncogene 1997; 14: 751–761
   PubMed Web of Science ®Google Scholar
• Frank S. J., Gilliland G., Kraft A. S., Arnold C. S. Interaction of the growth hormone receptor cytoplasmic domain with Jak2 tyrosine kinase. Endocrinology 1994; 135: 2228–2239
   PubMedGoogle Scholar
• Zhao Y., Wagner F., Frank S. J., Kraft A. S. The amino-terminal portion of the JAK2 protein kinase is necessary for binding and phosphorylation of the granulocyte-macrophage colony-stimulating factor receptor beta c chain. J. Biol. Chem. 1995; 270: 13814–13818
   PubMedGoogle Scholar
• Kohlhuber F., Rogers N. C., Watling D., Feng J., Guschin D., Briscoe J., Witthuhn B. A., Kotenko S. V., Pestka S., Stark G. R., et al. A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses. Mol. Cell. Biol. 1997; 17: 695–706
   PubMed Web of Science ®Google Scholar
• Chen M., Cheng A., Chen Y. Q., Hymel A., Hanson E. P., Kimmel L., Minami Y., Taniguchi T., Changelian P. S., O'Shear J. J. The amino terminus of JAK3 is necessary and sufficient for binding to the common G chain and confers the ability to transmit interleukin 2-mediated signals. Proc. Natl. Acad. Sci. USA 1997; 94: 6910–6915
   PubMed Web of Science ®Google Scholar
• Gauzzi M. C., Velazquez L., McKendry R., Mogensen K. E., Fellous M., Pellegrini S. Interferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase. J. Biol. Chem. 1996; 271: 20494–20500
   PubMed Web of Science ®Google Scholar
• Feng J., Witthuhn B. A., Matsuda T., Kohlhuber F., Kerr I. M., Ihle J. N. Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop. Mol. Cell. Biol. 1997; 17: 2497–2501
   PubMed Web of Science ®Google Scholar
• Mohammadi M., Schlessinger J., Hubbard S. R. Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell 1996; 86: 577–587
   PubMed Web of Science ®Google Scholar
• Harrison D. A., Binari R., Nahreini T. S., Gilman M., Perrimon N. Activation of a Drosophila Janus kinase (Jak) causes hematopoietic neoplasia and developmental defects. EMBO J. 1995; 14: 2857–2865
   PubMedGoogle Scholar
• Luo H., Hanratty W. P., Dearolf C. R. An amino acid substitution in the Drosophila hopTum-1 Jak kinase causes leukemia-like hematopoietic defects. EMBO J. 1995; 14: 1412–1420
   PubMed Web of Science ®Google Scholar
• Luo H., Rose P., Barber D., Hanratty W. P., Lee S., Roberts T. M., D'Andrea A. D., Dearolf C. R. Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-STAT pathways. Mol. Cell. Biol. 1997; 17: 1562–1571
   PubMed Web of Science ®Google Scholar
• Hou X. S., Melnick M. B., Perrimon N. Marelle acts downstream of the Drosophila HOP/Jak kinase and encodes a protein similar to the mammalian STATs. Cell 1996; 84: 411–419
   PubMed Web of Science ®Google Scholar
• Hou X. S., Perrimon N. The Jak-STAT pathway in Drosophila. Trends Genet. 1997; 13: 105–110
   PubMed Web of Science ®Google Scholar
• Yan R., Small S., Desplan C., Dearolf C. R., Darnell J. E.J. Identification of a Stat gene that functions in Drosophila development. Cell 1996; 84: 421–430
   PubMed Web of Science ®Google Scholar
• Yan R., Luo H., Darnell J. E.J, Dearolf C. R. A JAK-STAT pathway regulates wing vein formation in Drosophila. Proc. Natl. Acad. Sci. USA 1996; 93: 5842–5847
   PubMed Web of Science ®Google Scholar
• Kawata T., Shevchenko A., Fukuzawa M., Jermyn K. A., Totty N. F., Zhukovskaya N. V., Sterling A. E., Mann M., Williams J. G. SH2 signaling in a lower eukaryote: a STAT protein that regulates stalk cell differentiation in Dictyostelium. Cell 1997; 898: 909–916
   Google Scholar
• Greenlund A. C., Morales M. O., Viviano B. L., Yan H., Krolewski J., Schindler R. D. Stat recruitment by tyrosine-phosphorylated cytokine receptors: an ordered reversible affinity-driven process. Immunity 1995; 2: 677–687
   PubMed Web of Science ®Google Scholar
• Stahl N., Farruggella T. J., Boulton T. G., Zhong Z., Darnell J. E.J, Yancopoulos G. D. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 1995; 267: 1349–1353
   PubMed Web of Science ®Google Scholar
• Yamanaka Y., Nakajima K., Nakae H., Kojima H., Kiuchi N., Ichiba M., Kitaoka T., Fukada T., Hibi M., Hirano T. Differentiation and growth arrest signals generate through the cytoplasmic region of gp130 that is essential for Stat3 activation. EMBO J. 1996; 15: 1557–1565
   PubMed Web of Science ®Google Scholar
• Fujii H., Nakagawa Y., Schindler U., Kawahara A., Mori H., Gouilleux F., Groner B., Ihle J. N., Minami Y., Miyazaki T., Taniguchi T. Activation of StatS by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor β chain but is not essential for the proliferative signal transmission. Proc. Natl. Acad. Sci. USA 1995; 92: 5482–5486
   PubMed Web of Science ®Google Scholar
• Ascherman D. P., Migone T. S., Friedmann M. C., Leonard W. J. lnterleukin-2 (IL-2)-mediated induction of the IL-2 receptor alpha chain gene. Critical role of two functionally redundant tyrosine residues in the IL-2 receptor beta chain cytoplasmic domain and suggestion that these residues mediate more than Stat5 activation. J. Biol. Chem. 1997; 272: 8704–8709
   PubMedGoogle Scholar
• Schindler U., Wu P., Rothe M., Brasseur M., McKnight S. L. Components of a Stat recognition code: evidence for two layers of molecular selectivity. Immunity 1995; 6: 689–697
   Google Scholar
• Ryan J. J., McReynolds L. J., Keegan A., Wang L. H., Garfein E., Rothman P., Nelms K., Paue W. E. Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 1996; 4: 123–132
   PubMedGoogle Scholar
• Choi K. Y., Satterberg B., Lyons D. M., Elion E. A. Ste5 tethers multiple protein kinase the MAP kinase cascade required for mating in S. cerevisiae. Cell 1994; 78: 499–512
   PubMedGoogle Scholar
• Shuai K., Stark G., Kerr I. M., Darnell J. E.J. A single phosphotyrosine residue of Stat91 required for gene activation by interferon gamma. Science 1993; 261: 1744–1746
   PubMed Web of Science ®Google Scholar
• Zhong Z., Wen Z., Darnell J. E.J. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994; 164: 95–98
   Google Scholar
• Akira S., Nishio Y., Inoue M., Wang X. J., Wei S., Matsusaka T., Yoshida K., Sudo T., Naruto M., Kishimoto T. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130- mediated signaling pathway. Cell 1994; 77: 63–71
   PubMed Web of Science ®Google Scholar
• Nakajima K., Matsuda T., Fujitani Y., Kojima H., Yamanaka Y., Nakae K., Takeda T., Hirano T. Signal transduction through IL-6 receptor: involvement of multiple protein kinases, stat factors, and a novel H7-sensitive pathway. Ann. N. Y. Acad. Sci. 1995; 762: 55–70
   PubMed Web of Science ®Google Scholar
• Lin J. X., Mietz J., Modi W. S., John S., Leonard W. J. Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells
   Google Scholar
• Kojima H., Nakajima K., Hirano T. IL-6-inducible complexes on an IL-6 response element of the junB promoter contain Stat3 and 36kDa CRE-like site binding protein(s). Oncogene 1996; 12: 547–554
   PubMed Web of Science ®Google Scholar
• Xu X., Sun Y. L., Hoey T. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 1996; 273: 794–797
   PubMed Web of Science ®Google Scholar
• Sotiropoulos A., Moutoussamy S., Renaudie F., Clauss M., Kayser C., Gouilleuz F., Kelly P. A., Finidori J. Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor. Mol. Endocrinol. 1997; 10: 998–1009
   Google Scholar
• Yoshikawa A., Murakami H., Nagata S. Distinct signal transduction through the tyrosine-containing domains of the granulocyte colony-stimulating factor receptor. EMBO J. 1995; 14: 5288–5296
   PubMed Web of Science ®Google Scholar
• Li Z., Leung S., Kerr I. M., Stark G. R. Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling. Mol Cell. Biol. 1997; 17: 2048–2056
   PubMed Web of Science ®Google Scholar
• Sadowski H. B., Oilman M. Z. Cell-free activation of a DNA-binding protein by epidermal growth factor. Nature 1993; 362: 79–83
   PubMedGoogle Scholar
• Yu C. L., Meyer D. J., Campbell G. S., Larner A. C., Carter-Su C., Schwartz J., Jove R. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 1995; 269: 81–83
   PubMed Web of Science ®Google Scholar
• Cao X., Tay A., Guy G. R., Tan Y. H. Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol. Cell. Biol. 1996; 16: 1595–1603
   PubMed Web of Science ®Google Scholar
• Wen Z., Zhong Z., Darnell J. E.J. Maximal activation of transcription by Statl and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995; 82: 241–250
   PubMed Web of Science ®Google Scholar
• David M., Petricoin E. R., Benjamin C., Pine R., Weber M. J., Lamer A. C. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science 1995; 269: 1721–1723
   PubMed Web of Science ®Google Scholar
• Boulton T. G., Zhong Z., Wen Z., Darnell J. E.J., Stahl N., Yancopoulos G. D. STAT3 activation by cytokines utilizing gp 130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. Proc. Natl. Acad. Sci. USA 1995; 92: 6915–6919
   PubMed Web of Science ®Google Scholar
• Schindler C., Fu X. Y., Improta T., Aebersold R., Darnell J. E.J. Proteins of transcription factor ISGF-3: one gene encodes the 91- and 84-kDa ISGF-3 proteins that are activated by interferon alpha. Proc. Natl. Acad. Sci. USA 1992; 89: 7836–7839
   PubMed Web of Science ®Google Scholar
• Wang D., Stravopodis D., Teglund S., Kitazawa J., Ihle J. N. Naturally occurring dominant negative variants of Stat5. Mol. Cell. Biol. 1997; 16: 6141–6148
   Google Scholar
• Cardenhoven E., Vandijk T. B., Solar R., Armstrong J., Raaijmakers J. A.M., Lammers J. W.J., Koenderman L., DeGroot R. P. STAT3 beta, a splicing variant of transcription factor STAT3, is a dominant negative regulator of transcription. J. Biol. Chem. 1996; 271: 13221–13227
   Google Scholar
• Schaefer T. S., Sanders L. K., Nathans D. Cooperative transcriptional activity of Jun and Stat3β, a short form of Stat3. Proc. Natl. Acad. Sci. USA 1995; 89: 7836–7839
   Google Scholar
• Sasse J., Hemmann U., Schwartz C., Schniertshauer U., Heesel B., Landgraf C., Schneider-Mergener J., Heinrich P. C., Horn F. Mutational analysis of acute-phase response factor/Stat3 activation and dimerization. Mol. Cell. Biol. 1997; 17: 4677–4686
   PubMed Web of Science ®Google Scholar
• Bhattacharya S., Eckner R., Grossman S., Oldread E., Arany Z., D'Andrea A., Livingston D. M. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. Nature 1996; 383: 344–347
   PubMed Web of Science ®Google Scholar
• Horvai A. E., Xu L., Korzus E., Brard G., Kalafus D., Mullen T. M., Rose D. W., Rosenfeld M. G., Glass C. K. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc. Natl. Acad. USA 1997; 94: 1074–1079
   PubMedGoogle Scholar
• Zhang J. J., Vinkemeier U., Gu W., Charkravarti D., Horvath C. M., Darnell J. E.J. Two contact regions between Stat 1 and CBP/p300 in interferon gamma signaling. Proc. Natl. Acad. Sci. USA 1996; 93: 15092–15096
   PubMed Web of Science ®Google Scholar
• Sato N., Sakamaki K., Terada N., Arai K., Miyajima A. Signal transduction by the high-affinity GM-CSF receptor: two distinct cytoplasmic regions of the common beta subunit responsible for different signaling. EMBO J. 1993; 12: 4181–4189
   PubMed Web of Science ®Google Scholar
• Kumar G., Gupta S., Wang S., Nel A. E. Involvement of Janus kinases, p52shc, Raf-1, and MEK-1 in the IL-6-induced mitogen-activated protein kinase cascade of a growth-responsive B cell line. J. Immunol. 1994; 153: 4436–4447
   PubMed Web of Science ®Google Scholar
• Friedmann M. C., Migone T. S., Russel S. M., Leonard W. J. Different interleukin 2 receptor β-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc. Natl. Acad. Sci. USA 1996; 89: 11239–11243
   Google Scholar
• Wery S., Letourneur M., Bertoglio J., Pierre J. Interleukin-4 induces activation of mitogen-activated protein kinase and phosphorylation of she in human keratinocytes. J. Biol. Chem. 1996; 271: 8529–8532
   PubMed Web of Science ®Google Scholar
• Gurney A. L., Wong S. C., Henzel W. J., de-Sauvage F. J. Distinct regions of c-Mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and She phosphorylation. Proc. Natl. Acad. Sci. USA 1995; 92: 5292–5296
   PubMed Web of Science ®Google Scholar
• Fukada T., Hibi M., Yamanaka Y., Takahashi-Tezuka M., Fujitani Y., Yamaguchi T., Nakajima K., Hirano T. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity 1996; 5: 449–460
   PubMed Web of Science ®Google Scholar
• Watanabe S., Itoh T., Arai K. Roles of JAK kinases in human GM-CSF receptor signal transduction. J. Allergv Clin. Immunol. 1996; 98: S183–191
   PubMed Web of Science ®Google Scholar
• Bennett A. M., Housdorff S. F., O'Reilly A. M., Freeman R. O., Jr., Neel B. G. Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression. Mol. Cell. Biol. 1996; 16: 1189–1202
   PubMed Web of Science ®Google Scholar
• Noguchi T., Matozaki T., Horita K., Fujioka Y., Kasuga M. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation. Mol. Cell. Biol. 1994; 14: 6674–6682
   PubMed Web of Science ®Google Scholar
• Tang T. L., Freeman R. M., Jr., O'Reilly A. M., Neel B. G., Sokol S. Y. The SH2-containing protein-tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early Xenopus development. Cell 1995; 80: 473–483
   PubMed Web of Science ®Google Scholar
• Perkins L. A., Larsen I., Perrimon N. Corkscrew encodes a putative protein tyrosine phosphatase that functions to transduce the terminal signal from the receptor tyrosine kinase torso. Cell 1992; 70: 225–236
   PubMed Web of Science ®Google Scholar
• Perkins L. A., Johnson M. R., Melnick M. B., Perrimon N. The nonreceptor protein tyrosine phosphatase corkscrew functions in multiple receptor tyrosine kinase pathway in Drosophila. Dev. Biol. 1996; 180: 63–81
   PubMed Web of Science ®Google Scholar
• Songyang Z., Shoelson S. E., Chaudhuri M., Gish G., Pawson T., Haser W. G., King F., Roberts T., Ratnofsky S., Lechleider R. J., et al. SH2 domains recognize specific phosphopeptide sequences. Cell 1993; 72: 767–778
   PubMed Web of Science ®Google Scholar
• Bennett A. M., Tang T. L., Sugimoto S., Walsh C. T., Neel B. G. Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor beta to Ras. Proc. Natl. Acad. Sci. USA 1994; 91: 7335–7339
   PubMed Web of Science ®Google Scholar
• Adachi M., Ishino M., Torigoe T., Minami Y., Matozaki T., Miyazaki T., Taniguchi T., Hinoda Y., Imai K. Interleukin-2 induces tyrosine phosphorylation of SHP-2 through IL-2 receptor beta chain. Oncogene 1996; 14: 1629–1633
   Google Scholar
• Yin T., Shen R., Feng G. S., Yang Y. C. Molecular characterization of specific interactions between SHP-2 phosphatase and JAK. tyrosine kinases. J. Biol. Chem. 1997; 212: 1032–1037
   Google Scholar
• Herbst R., Carroll R. M., Allard J. D., Schilling J., Raabe T., Simon M. A. Daughter of Sevenless is a substrate of the phosphotyrosine phosphatase Corkscrew and functions during Sevenless signaling. Cell 1996; 85: 899–909
   PubMed Web of Science ®Google Scholar
• Raabe T., Riesgo-Escovar J., Liu X., Bausenwein B. S., Deak P., Maroy P., Hafen H. DOS, a novel pleckstrin homology domain-containing protein required for signal transduction between Sevenless and Rasl in Drosophila. Cell 1996; 85: 911–920
   PubMed Web of Science ®Google Scholar
• Johnston J. A., Wang L. M., Hanson E. P., Sun X. J., White M. F., Oakes S. A., Pierce J. H., O'Shea J. J. Interleukin 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases. J. Biol. Chem. 1995; 270: 28527–28530
   PubMed Web of Science ®Google Scholar
• Burfoot M. S., Rogers N. C., Watling D., Smith J. M., Pons S., Ciliberto G., Pellegrini S., White M. F., Kerr I. M. Janus kinase-dependent activation of insulin receptor substrate-1 in response to interleukin-4, oncostatin M and the interferons. J. Biol. Chem. 1997; 272: 24183–24190
   PubMed Web of Science ®Google Scholar
• Holgado-Madruga M., Emlet D. R., Mosacatello D. K., Godwin A. K., Wang A. J. Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 1996; 319: 560–564
   Google Scholar
• Weidner K. M., Di-Cesare S., Sachs M., Brinkmann V., Behrens J., Birchmeier W. Interaction between Gab1 and c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature 1997; 384: 173–176
   Google Scholar
• Takahashi-Tezuka M., Yoshida Y., Fukada T., Yamaguchi T., Yamanaka Y., Nakajima K., Hibi M., Hirano T., submitted
   Google Scholar
• Wang L. M., Keegan A., Frankel M., Paul W. E., Pierce J. H. Signal transduction through the IL-4 and insulin receptor families. Stem Cells Dayt. 1995; 13: 360–8
   PubMedGoogle Scholar
• Keegan A. D., Nelms K., White M., Wang L. M., Pierce J. H., Paul W. E. An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 1994; 76: 811–820
   PubMed Web of Science ®Google Scholar
• Damen J. E., Cutler R. L., Jiao H., Yi T., Krystal G. Phosphorylation of tyrosine 503 in the erythropoietin receptor (EpR) is essential for binding the P85 subunit of phosphatidylinositol (PI) 3-kinase and for EpR-associated PI 3-kinase activity. J. Biol. Chem. 1995; 270: 23402–23408
   PubMed Web of Science ®Google Scholar
• Miura O., Nakamura N., Ihle J. N., Aoki N. Erythropoietin- dependent association of phosphatidylinositol 3-kinase with tyrosine-phosphory- lated erythropoietin receptor. J. Biol. Chem. 1994; 269: 614–620
   PubMed Web of Science ®Google Scholar
• Sharfe N., Dadi H. K., Roifman C M. JAK3 protein tyrosine kinase mediates interleukin-7-induced activation of phosphatidylinositol-3′ kinase. Blood 1995; 86: 2077–2085
   PubMed Web of Science ®Google Scholar
• Takahashi-Tezuka M., Hibi M., Fujitani Y., Fukada T., Yamaguchi T., Hirano T. Tec tyrosine kinase links the cytokine receptors to PI-3 kinase probably through JAK. Oncogene 1997; 14: 2273–2282
   PubMedGoogle Scholar
• Pfeffer L. M., Mullersman J. E., Pfeffer S. R., Murti A., Shi W., Yang C. H. STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor. Science 1997; 276: 1418–1420
   PubMed Web of Science ®Google Scholar
• Matsuda T., Yamanaka Y., Hirano T. Interleukin-6-induced tyrosine phosphorylation of multiple proteins in murine hematopoietic lineage cells. Biochem. Biophys. Res. Commun. 1995; 200: 821–828
   Google Scholar
• Machide M., Mano H., Todokoro K. Interleukin 3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain. Oncogene 1995; 11: 619–625
   PubMed Web of Science ®Google Scholar
• Crespo P., Schuebel K. E., Ostrom A. A., Gutkind J. S., Bustelo X. R. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 1997; 385: 169–172
   PubMed Web of Science ®Google Scholar
• Raush O., Marshall C. J. Tyrosine 763 of the murine granulocyte colony-stimulating factor receptor mediates Ras dependent activation the JNK/SAPK mitogen-activated protein kinase pathway. Mol. Cell. Biol. 1997; 17: 1170–1179
   Google Scholar
• Takeshita T., Arita T., Higuchi M., Asao H., Endo K., Kuroda H., Tanaka N., Marata K., Ishii N., Sugamura K. STAT, signal transducing adapter molecule, is associated with janus kinases and involved in signaling for cell growth and c-myc induction. Immunity 1997; 6: 449–457
   PubMed Web of Science ®Google Scholar
• Klingmuller U., Lorenz U., Cantley L. C., Neel B. G., Lodish H. F. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 1995; 80: 729–738
   PubMed Web of Science ®Google Scholar
• Starr R., Willson T. A., Viney E. M., Murray L. J., Rayner J. R., Jenkins B. J., Gonda T. J., Alexander W. S., Metcalf D., Nicola N. A., Hilton D. A family of cytokine inducible inhibitors of signaling. Nature 1997; 387: 917–921
   PubMed Web of Science ®Google Scholar
• Endo T. A., Masuhara M., Yokouchi M., Suzuki R., Sakamoto H., Mitsui K., Matusmoto A., et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997; 387: 921–924
   PubMed Web of Science ®Google Scholar
• Naka T., Narazaki M., Hirata M., Matsumoto T., Minamoto S., Aono A., Nishimoto N., Kajita T., et al. Structure and function of a new STAT- induced STAT inhibitor. Nature 1997; 387: 924–929
   PubMed Web of Science ®Google Scholar
• Durbin J. E., Hackenmiller R., Simon M. C., Levy D. E. Targeted disruption of the mouse Stat 1 gene results in compromised innate immunity to viral disease. Cell 1996; 84: 443–450
   PubMed Web of Science ®Google Scholar
• Meraz M. A., White J. M., Sheehan K. C., Bach E. A., Rodig S. J., Dighe A. S., Kaplan D. H., Riley J. K., Greenlund A. C., Campbell D., et al. Targeted disruption of the Statl gene in mice reveals unexpected physiologic specificity in the Jak-STAT signaling pathway. Cell 1996; 84: 431–442
   PubMed Web of Science ®Google Scholar
• Chin Y. E., Kitagawa M., Su W. C., You Z. H., Iwamoto Y., Fu X. Y. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF/CIP mediated by STAT1. Science 1996; 272: 719–722
   PubMed Web of Science ®Google Scholar
• Chin Y. E., Kitagawa M., Kuida K., Flavell R. A., Fu X. Y. Activation of STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol. Cell. Biol. 1997; 17: 5328–5337
   PubMed Web of Science ®Google Scholar
• Takeda K., Noguchi K., Shi W., Tanaka T., Matsumoto M., Yoshida N., Kishimoto T., Akira S. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA 1997; 94: 3801–3804
   PubMed Web of Science ®Google Scholar
• Nakajima K., Yamanaka Y., Nakae K., Kojima H., Ichiba M., Kiuchi N., Kitaoka T., Fukada T., Hibi M., Hirano T. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J. 1996; 15: 3651–3658
   PubMed Web of Science ®Google Scholar
• Minami M., Inoue M., Wei S., et al. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc. Natl. Acad. Sci. USA 1996; 93: 3963–3966
   PubMed Web of Science ®Google Scholar
• Shimozaki K., Nakajima K., Hirano T., Nagata S. Involvement of STAT3 in the granulocyte colony stimulating factor-induced differentiation of myeloid cells. J. Biol. Chem. 1997; 272: 25184–25189
   PubMed Web of Science ®Google Scholar
• Boeuf H., Hauss C., De Graeve F., Baran N., Kedinger C. Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells. J. Cell. Biology 1997; 138: 1207–1217
   PubMed Web of Science ®Google Scholar
• Morese L., Chen D., Franklin D., Xiong Y., Chen-Kiang S. Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18INK4c and IL-6. Immunity 1997; 6: 47–56
   Google Scholar
• Narimatsu M., Nakajima K., Ichiba M., Hirano T. Association of Stat3-dependent transcriptional activation of p19INK4D with the IL-6-induced growth arrest. Biochem. Biophys. Res. Comm. 1997; 238: 764–768
   PubMed Web of Science ®Google Scholar
• Kaplan M. H., Sun Y. L., Hoey T., Grusby M. J. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 1996; 382: 174–177
   PubMed Web of Science ®Google Scholar
• Thierfelder W. E., van Deursen J. M., Yamamoto K., Tripp R. A., Sarawar S. R., Carson R. T., Sangster M. Y., Vignali D. A., Doherty P. C., Grosveld G. C., Ihle J. N. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 1996; 382: 171–174
   PubMed Web of Science ®Google Scholar
• Liu X., Robinson G. W., Wagner K. U., Garrett L., Wynshaw-Boris A., Hennighausen L. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 1997; 11: 179–186
   PubMed Web of Science ®Google Scholar
• Udy G. B., Towers R. P., Snell R. G., Wilkins R. J., Park S.-H., Ram P. A., Waxman D. J., Davey H. W. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA 1997; 94: 7239–7244
   PubMed Web of Science ®Google Scholar
• Gobert S., Chretien S., Gouilleux F., Muller O., Pallard C., Dusanter-Fourt I., Groner B., Lacombe C., Gisselbrecht S., Mayeux P. Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation. EMBO J. 1996; 15: 2334–2341
   Google Scholar
• Quelle F. W., Wang D., Nosaka T., Thierfelder W. E., Stravopodis D., Weinstein Y., Ihle J. N. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol. Cell. Biol., 16: 1622–1631
   Google Scholar
• Muli A. L., Wakao H., Kinoshita T., Kitamura T., Miyajima A. Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J. 1996; 15: 2425–2433
   PubMedGoogle Scholar
• Kaplan M. H., Schindler U., Smiley S. T., Grusby M. J. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 1996; 4: 313–319
   PubMed Web of Science ®Google Scholar
• Shimoda K., van Deursen J., Sangster M. Y., Sarawar S. R., Carson R. T., Trpp R. A., Chu C., Quelle F. W., Nosaka T., Vignali D. A., et al. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 genes. Nature 1996; 380: 630–633
   PubMed Web of Science ®Google Scholar
• Takeda K., Tanaka T., Shi W., Matsumoto M., Minami M., Kashiwamura S., Nakanishi K., Yoshida N., Kishimoto T., Akira S. Essential role of Stat6 in IL-4 signaling. Nature 1996; 380: L627–630
   PubMed Web of Science ®Google Scholar
• Binari R., Perrimon N. Stripe-specific regulation of pair-rule genes by hopscotch, a putative Jak family tyrosine kinase in Drosophila. Genes Dev. 1994; 8: 300–312
   PubMed Web of Science ®Google Scholar
• Kinoshita T., Yokota T., Arai K., Miyajima A. Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors. EMBO J. 1995; 14: 266–275
   PubMed Web of Science ®Google Scholar
• Ihara S., Nakajima K., Fukada T., et al. Dual control of neurite outgrowth by STAT3 and MAP kinase in PC 12 cells stimulated with interleukin-6. EMBO J. 1997; 17: 5345–5352
   Google Scholar
• Nosaka T., van Deursen J. M., Tripp R. A., Thierfelder W. E., Witthuhn B. A., McMickle A. P., Doherty P. C., Grosveld G. C., Ihle J. N. Defective lymphoid development in mice lacking Jak3. Science 1995; 270: 800–802
   PubMed Web of Science ®Google Scholar
• Park S. Y., Saijo K., Takahashi T., Osawa M., Arase H., Hirayama N., Miyake K., Nakauchi H., Shirasawa T., Saito T. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 1995; 3: 771–782
   PubMed Web of Science ®Google Scholar
• Coneway G, Margoliath A., Wong-Madden S., Roberts R. J., Gilbert W. Jakl kinase is required for cell migrations and anterior specification in zebrafish embryos. Proc. Natl. Acad. Sci. USA 1997; 94: 3082–3087
   Google Scholar